acetaminophen has been researched along with griseofulvin in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (9.09) | 18.7374 |
1990's | 4 (18.18) | 18.2507 |
2000's | 7 (31.82) | 29.6817 |
2010's | 7 (31.82) | 24.3611 |
2020's | 2 (9.09) | 2.80 |
Authors | Studies |
---|---|
Duffy, EM; Jorgensen, WL | 1 |
Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Richens, A | 1 |
Atkins, CE; Johnson, RK | 1 |
Breäs, R; Crommelin, DJ; Poelma, FG; Tukker, JJ | 1 |
Breäs, R; Poelma, FG; Tukker, JJ | 1 |
Kasper, P; Müller, L | 1 |
Broome, RL; Ku, NO; Michie, SA; Omary, MB; Oshima, RG; Resurreccion, EZ; Soetikno, RM | 1 |
Chan, C; Chiang, PC; Chou, KJ; Cui, Y; Hart, R; Ran, Y; Sambrone, A | 1 |
Abusnana, S; Al Heialy, S; Alghamdi, M; Halwani, R; Hamid, Q; Kashour, T; Mdkhana, B; Ratemi, E; Saheb Sharif-Askari, F; Saheb Sharif-Askari, N | 1 |
Halbert, GW; Khadra, I; Pyper, K; Silva, MI | 1 |
4 review(s) available for acetaminophen and griseofulvin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Interactions with antiepileptic drugs.
Topics: Acetaminophen; Acetazolamide; Anti-Anxiety Agents; Anticoagulants; Anticonvulsants; Carbamazepine; Diazepam; Drug Interactions; Furosemide; Gonadal Steroid Hormones; Griseofulvin; Humans; Phenobarbital; Phenytoin; Primidone; Thiazines; Urea; Valproic Acid; Vitamin D | 1977 |
Clinical toxicities of cats.
Topics: Acetaminophen; Animals; Arsenic Poisoning; Aspirin; Benzoates; Bismuth; Cat Diseases; Cats; Chloramphenicol; Dichlorvos; Diuresis; Ethylene Glycols; Fuel Oils; Gastric Lavage; Griseofulvin; Hexachlorophene; Insecticides; Lead Poisoning; Mercury Poisoning; Methylene Blue; Morphine; Pentobarbital; Phenacetin; Phenols; Plant Poisoning; Rodenticides; Strychnine; Vitamin A | 1975 |
OTC pharmaceuticals and genotoxicity testing: the paracetamol, anthraquinone, and griseofulvin cases.
Topics: Acetaminophen; Animals; Anthraquinones; Griseofulvin; Humans; Nonprescription Drugs; Teratogens | 1995 |
18 other study(ies) available for acetaminophen and griseofulvin
Article | Year |
---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Intestinal absorption of drugs. The influence of mixed micelles on on the disappearance kinetics of drugs from the small intestine of the rat.
Topics: Acetaminophen; Animals; Chromatography, High Pressure Liquid; Dantrolene; Griseofulvin; Intestinal Absorption; Intestine, Small; Ketoconazole; Kinetics; Lysophosphatidylcholines; Micelles; Models, Biological; Mucus; Rats; Solubility; Swine; Taurocholic Acid; Theophylline | 1991 |
Intestinal absorption of drugs. III. The influence of taurocholate on the disappearance kinetics of hydrophilic and lipophilic drugs from the small intestine of the rat.
Topics: Acetaminophen; Animals; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Griseofulvin; In Vitro Techniques; Intestinal Absorption; Intestine, Small; Ketoconazole; Models, Biological; Perfusion; Pharmacokinetics; Rats; Solubility; Taurocholic Acid; Theophylline | 1990 |
Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant.
Topics: Acetaminophen; Animals; Electrophoresis, Gel, Two-Dimensional; Fluorescent Antibody Technique, Indirect; Genes, Dominant; Glycosylation; Griseofulvin; Humans; Keratins; Liver; Mice; Mice, Transgenic; Organ Size; Phosphorylation; Survival Analysis | 1996 |
Evaluation of drug load and polymer by using a 96-well plate vacuum dry system for amorphous solid dispersion drug delivery.
Topics: Acetaminophen; Celecoxib; Chemistry, Pharmaceutical; Crystallization; Drug Carriers; Drug Stability; Equipment Design; Griseofulvin; High-Throughput Screening Assays; Hypromellose Derivatives; Indomethacin; Kinetics; Methylcellulose; Miniaturization; Pharmaceutical Preparations; Polymers; Povidone; Pyrazoles; Quality Control; Reproducibility of Results; Solubility; Solvents; Sulfonamides; Technology, Pharmaceutical; Vacuum; Water | 2012 |
Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue.
Topics: Acetaminophen; Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Cells, Cultured; Coronavirus Infections; COVID-19; Dose-Response Relationship, Drug; Griseofulvin; Hepatocytes; Host-Pathogen Interactions; Humans; Hypoglycemic Agents; Liver; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Rats; SARS-CoV-2; Serine Endopeptidases; Virus Internalization | 2020 |
Fed intestinal solubility limits and distributions applied to the Developability classification system.
Topics: Acetaminophen; Administration, Oral; Griseofulvin; Humans; Intestinal Absorption; Intestines; Pharmaceutical Preparations; Solubility | 2023 |